三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
NTLA-2001临床I期研究设计
NTLA-2001临床I期研究设计
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:316KB
图片尺寸:1948*712
同报告图片
/
4
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
所属报告:
医药生物行业:基因编辑逆转先天缺陷基因编辑治疗生物医学的明珠-230703(59页).pdf
打包全文图表
相关数据
NTLA-2001临床试验结果
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
收藏
其它
2024-04-22
原图定位
查看详情
NTLA-2002临床试验结果
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
收藏
其它
2024-04-22
原图定位
查看详情
NTLA-2001临床I期针对心肌疾病(ATTR-CM)的设计
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
收藏
行业数据
2023-07-05
原图定位
查看详情
NTLA-2002带来临床获益:部分患者已可以不再接受传统的预防治疗
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
收藏
行业数据
2023-07-05
原图定位
查看详情
NTLA-2002带来临床获益:降低HAE发病频率
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
收藏
行业数据
2023-07-05
原图定位
查看详情
ATTR-CM临床I期NTLA-2001降低血清TTR的有效性数据
fCDmnIjku70gfCBOWUhBIENsYXNzIElJL0lJSSAwLjcgbWcva2cgKG49MykgfCBOWUhBIENsYXNzIElJSSAwLjcgbWcva2cgKG49NikgfCBOWUhBIENsYXNzIElJL0lJSSAxLjAgbWcva2cgKG49MyopIHwKfC0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfAp8IOWfuue6vyB8IDAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgMCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCAxICAgIHwgLTkwICAgICAgICAgICAgICAgICAgICAgICAgIHwgLTkwICAgICAgICAgICAgICAgICAgICAgICAgICAgfCAtOTAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIgICAgfCAtOTAgICAgICAgICAgICAgICAgICAgICAgICAgfCAtOTAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IC05MCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgNCAgICB8IC05NCAgICAgICAgICAgICAgICAgICAgICAgICB8IC05NCAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgLTk0ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCA2ICAgIHwgLTkzICAgICAgICAgICAgICAgICAgICAgICAgIHwgLTkzICAgICAgICAgICAgICAgICAgICAgICAgICAgfCAtOTMgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77yaSW50ZWxsaWEgVGhlcmFwZXV0aWNzLCDkuK3pk7bor4HliLg=
收藏
行业数据
2023-07-05
原图定位
查看详情
NTLA-2002显著降低血浆Kallikrein水平
fCBEb3NlIExldmVsIHwgUGxhc21hIEthbGxpa3JlaW4gUmVkdWN0aW9uICglKSB8IG4gfAp8LS0tfC0tLXwtLS18IAp8IDI1IG1nIHwgLTY0JSB8IDMgfAp8IDUwIG1nIHwgLTgxJSB8IDQgfAp8IDc1IG1nIHwgLTkyJSB8IDMgfA==
收藏
行业数据
2023-07-05
原图定位
查看详情
NTLA-2002临床I/II期研究设计
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
收藏
行业数据
2023-07-05
原图定位
查看详情
NTLA-2001临床I期针对多发性神经疾病(ATTRv-PN)的设计
fCBQQVJUIEkgLSBTaW5nbGUtQXNjZW5kaW5nIERvc2UgfCAKfC0tLXwKfCAxLjAgbWcva2cgKG49NikgfCAKfCAwLjcgbWcva2cgKG49MykgfCAKfCAwLjMgbWcva2cgKG49MykgfCAKfCAwLjEgbWcva2cgKG49MykgfCAKCnwgUEFSVCBJSSAtIERvc2UgRXhwYW5zaW9uIHwgCnwtLS18CnwgODAgbWcgfCAKfCA1NSBtZyogfCAKCui1hOaWmeadpea6kO+8mkludGVsbGlhIFRoZXJhcGV1dGljc++8jOS4remTtuivgeWIuA==
收藏
行业数据
2023-07-05
原图定位
查看详情
ATTRv-PN临床I期NTLA-2001降低血清TTR的有效性数据
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
收藏
行业数据
2023-07-05
原图定位
查看详情
NTLA-2001临床I期针对ATTR引起的心肌疾病(ATTRv-CM)的安全性
fCBQYXJhbWV0ZXIgfCBOWUhBIENsYXNzIElJL0lJSSAwLjcgbWcva2cgbiA9IDMgfCBOWUhBIENsYXNzIElJSSAwLjcgbWcva2cgbiA9IDYgfCBOWUhBIENsYXNzIElJL0lJSSAxLjAgbWcva2cgbiA9IDMgfCBBbGwgUGF0aWVudHMgbiA9IDEyIHwKfCAtLS0gfCAtLS0gfCAtLS0gfCAtLS0gfCAtLS0gfAp8IFBhdGllbnRzIHdpdGggYXQgbGVhc3Qgb25lIFRFQUUgfCAyIHwgMyB8IDEgfCA2IHwKfCBJbmZ1c2lvbi1yZWxhdGVkIHJlYWN0aW9uIHwgLSB8IC0gfCAxIHwgMSB8CnwgQ09WSUQtMTkgfCAtIHwgMSB8IC0gfCAyIHwKCui1hOaWmeadpea6kO+8mkludGVsbGlhIFRoZXJhcGV1dGljc++8jOS4remTtuivgeWIuA==
收藏
行业数据
2023-07-05
原图定位
查看详情
NTLA-2002治疗HAE机制
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
收藏
行业数据
2023-07-05
原图定位
查看详情
NTLA-2001临床I期针对遗传性ATTR引起的多发性神经疾病(ATTRv-PN)的安全性
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
收藏
行业数据
2023-07-05
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
临床设计 Intellia 的 NTLA-2001 已进入临床 I 期研究,这是一项针对 2 项适应症进行的开放标签、多中心研究。研究分别对药物在遗传性 ATTR 引起的多发性神经疾病(ATTRv-PN)和 ATTR 引起的心肌疾病(ATTR-CM)的治疗展开了探索。两个适应症的给药方式均采取 1 剂次静脉注射(IV)。两个适应症的研究均分为两个部分,第一部分为单剂次剂量爬坡,第二部分为剂次扩张(以第一部分研究后选定的剂量为基础)。
行业数据
原图定位
当前图表所属:
医药生物行业:基因编辑逆转先天缺陷基因编辑治疗生物医学的明珠-230703(59页).pdf
CRISPR对抗病毒入侵机制
TALEffector+FokI二倍体
TALEffector与DNA结合后的三维结构示意
TALEffector中一个repeat单位的蛋白三维结构示意
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》